ICD-10 Coding for Hodgkin's Disease(C81.00, C81.00B, C81.00N)
Comprehensive guide to ICD-10 coding for Hodgkin's disease, including remission and active disease codes, documentation requirements, and coding pitfalls.
Complete code families applicable to Hodgkin's Disease
Compare key differences between these codes to ensure accurate selection
| Code | Description | When to Use | Key Documentation |
|---|---|---|---|
| C81.00 | Nodular lymphocyte predominant Hodgkin lymphoma, unspecified site | Use when the specific site of nodular lymphocyte predominant Hodgkin lymphoma is not specified. |
|
| C81.0A | Hodgkin lymphoma in remission | Use when the patient is in remission but still under surveillance. |
|
Clinical Decision Support
Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.
Key Information
Essential facts and insights aboutHodgkin's Disease
Alternative codes to consider when ruling out similar conditions
Documentation & Coding Risks
Avoid these common issues when documenting Hodgkin's Disease.
Documenting 'Hodgkin's disease' without subtype
Impact
Clinical: May lead to inappropriate treatment decisions., Regulatory: Non-compliance with documentation standards., Financial: Potential for claim denials due to unspecified coding.
Mitigation
Train staff on the importance of subtype documentation, Use templates that prompt for subtype entry
Using C81 without specifying the fifth character
Impact
Reimbursement: Incorrect coding can lead to denied claims., Compliance: Non-compliance with ICD-10 coding guidelines., Data Quality: Inaccurate data collection for disease tracking.
Mitigation
Always use a specific 5-character code to indicate the type and site of Hodgkin lymphoma.
Remission Coding
Impact
Incorrect use of remission vs. history codes.
Mitigation
Ensure clear documentation of remission status and surveillance.